Non Hodgkin Lymphoma

Study shows promising clinical activity

Immune cellular therapy is a promising new area of cancer treatment. Anti-cancer therapeutics, such as chimeric antigen receptor (CAR) modified T cells, can be engineered to target tumor-associated antigens to attack and ...

10 hours ago
popularity0 comments 0

Study estimates global cancer cases, deaths in 2015

In 2015, there were an estimated 17.5 million cancer cases around the globe and 8.7 million deaths, according to a new report from the Global Burden of Disease Cancer Collaboration published online by JAMA Oncology.

Dec 03, 2016
popularity1 comments 0

DNA sequencing determines lymphoma origin, prognosis

Sequencing tiny bits of DNA circulating in the blood of patients with lymphoma can accurately identify the cancer subtype and pinpoint mutations that might cause drug resistance, according to researchers at the Stanford University ...

Nov 09, 2016
popularity86 comments 0

The non-Hodgkin lymphomas (NHLs) are a diverse group of blood cancers that include any kind of lymphoma except Hodgkin's lymphomas. Types of NHL vary significantly in their severity, from indolent to very aggressive.

Lymphomas are types of cancer derived from lymphocytes, a type of white blood cell. Lymphomas are treated by combinations of chemotherapy, monoclonal antibodies, immunotherapy, radiation, and hematopoietic stem cell transplantation.

Non-Hodgkin lymphomas were classified according to the 1982 Working Formulation which recognizes 16 types. The Working Formulation is now considered obsolete, and the classification is commonly used primarily for statistical comparisons with previous decades. The Working Formulation has been superseded twice.

The latest lymphoma classification, the 2008 WHO classification, largely abandoned the "Hodgkin" vs. "Non-Hodgkin" grouping. Instead, it lists over 80 different forms of lymphomas in four broad groups.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

New, more effective strategy for producing flu vaccines

A team of researchers led by Yoshihiro Kawaoka, professor of pathobiological sciences at the University of Wisconsin-Madison School of Veterinary Medicine, has developed technology that could improve the production of vaccines ...

An eye on young specialists' success

Graduates from several medical and surgical specialties are having difficulty securing practice opportunities, especially in specialties dependent upon limited resources, according to new research from Queen's ophthalmologist ...

Protecting babies from eczema with low-cost Vaseline

What if it was possible to prevent your child from getting eczema—a costly, inflammatory skin disorder—just by applying something as inexpensive as petroleum jelly every day for the first six months of his or her life?